Magnolol Potentiates Sorafenib-induced Apoptosis and Inhibits Metastatic Signaling in Renal Carcinoma.

Chang CC, Hung MY, Weng YS, Chang CM, Hsu FT, Chen YH, Chen JH.

Open source

DOI
10.21873/invivo.14426
Published
2026-09-01
Container
In Vivo
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21873/invivo.14426,
  title = {Magnolol Potentiates Sorafenib-induced Apoptosis and Inhibits Metastatic Signaling in Renal Carcinoma.},
  author = {Chang CC and  Hung MY and  Weng YS and  Chang CM and  Hsu FT and  Chen YH and  Chen JH.},
  year = {2026},
  journal = {In Vivo},
  doi = {10.21873/invivo.14426},
  url = {https://doi.org/10.21873/invivo.14426}
}

RIS

TY  - JOUR
TI  - Magnolol Potentiates Sorafenib-induced Apoptosis and Inhibits Metastatic Signaling in Renal Carcinoma.
AU  - Chang CC
AU  -  Hung MY
AU  -  Weng YS
AU  -  Chang CM
AU  -  Hsu FT
AU  -  Chen YH
AU  -  Chen JH.
PY  - 2026
JO  - In Vivo
DO  - 10.21873/invivo.14426
UR  - https://doi.org/10.21873/invivo.14426
ER  - 

APA

CC, C., MY, H., YS, W., CM, C., FT, H., YH, C., & JH., C. (2026). Magnolol Potentiates Sorafenib-induced Apoptosis and Inhibits Metastatic Signaling in Renal Carcinoma.. In Vivo. https://doi.org/10.21873/invivo.14426

Source records